Exploring studies and advances in thoracic oncology showcased at the IASLC WCLC 2020 Virtual Presidential Symposium on 8th August and the potential implications on UK practice.

Programme

Chair: Professor Sanjay Popat

The faculty will disseminate the trial data presented, discuss in UK context, and take questions.

ORIENT-11

Alastair Greystoke

Abstract 1: ORIENT-11: Sintilimab + Pemetrexed + Platinum as First-Line Therapy for Locally Advanced or Metastatic Non-Squamous NSCLC

(Speaker: Zhang Li, China)

eXalt3

Fiona Blackhall

Abstract 2: Phase 3 Randomized Study of Ensartinib vs Crizotinib in Anaplastic Lymphoma Kinase (ALK)–Positive NSCLC Patients: eXalt3

(Speaker: Leora Horn, USA)

CheckMate-743

Riyaz Shah

Abstract 3: First-Line Nivolumab + Ipilimumab vs Chemotherapy in Unresectable Malignant Pleural Mesothelioma: CheckMate 743

(Speaker: Paul Baas, Netherlands)

Faculty

Professor Sanjay Popat is Consultant Thoracic Medical Oncologist at the Royal Marsden Hospital and Professor of Thoracic Oncology at the Institute of Cancer Research and Chair of the BTOG Steering Committee

Dr Alastair Greystoke is Clinical Senior Lecturer and Honorary Consultant at the Newcastle University and the Northern Centre for Cancer Care

Professor Fiona Blackhall is Professor of Thoracic Oncology and Honorary Consultant in Medical Oncology at the Christie NHS Foundation Trust

Dr Riyaz Shah is a Consultant Medical Oncologist at Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust